Contribution of nitric oxide in big endothelin-1-induced cardioprotective effects on ischemia/reperfusion injury in rat hearts

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 5, 2011, Pages 575-578

  Tawa, Masashi ^a,b   Fukumoto, Taiki ^a   Ohkita, Mamoru ^a   Yamashita, Naoto ^a   Geddawy, Ayman ^b   Imamura, Takeshi ^b   Ayajiki, Kazuhide ^b,c   Okamura, Tomio ^b   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

ETB receptor; ischemia reperfusion; nitric oxide

Indexed keywords

4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; BIG ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; SM 19712; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REPERFUSION INJURY;

ANIMALS; CARDIOTONIC AGENTS; ENDOTHELIN-1; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B;

EID: 79957714531     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821325ad     Document Type: Article

References (21)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415 (Pubitemid 18090241)
2. Brunner F, Du Toit EF, Opie LH. Endothelin release during ischemia and reperfusion of isolated perfused rat hearts. J Mol Cell Cardiol. 1992;24: 1291-1305 (Pubitemid 23016052)
3. Tawa M, Fukumoto T, Ohkita M, et al. Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts. Eur J Pharmacol. 2008;591:182-188
4. Schömig A, Haass M, Richardt G. Catecholamine release and arrhythmias in acute myocardial ischemia. Eur Heart J. 1991;12(suppl F):38-47
5. Li XS, Wang QD, Pernow J. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Eur J Pharmacol. 1995;283:161-168
6. Illing B, Horn M, Han H, et al. Protective effect of the specific endothelin- 1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts. J Cardiovasc Pharmacol. 1996;27:487-494 (Pubitemid 26111069)
7. Yamamoto S, Matsumoto N, Kanazawa M, et al. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts. Circulation. 2005; 111:302-309 (Pubitemid 40165336)
8. Tawa M, Fukumoto T, Ohkita M, et al. Effects of exogenous big endothelin-1 on post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts. Hypertens Res. 2011;34:218-224
9. Murohara T, Lefer AM. Autocrine effects of endothelin-1 on leukocyteendothelial interaction: stimulation of endothelin B receptor subtype reduces endothelial adhesiveness via a nitric oxide-dependent mechanism. Blood. 1996;88:3894-3900 (Pubitemid 26383113)
10. Matsuo G, Matsumura Y, Tadano K, et al. Effects of sarafotoxin S6c on renal haemodynamics and urine formation in anaesthetized dogs. Clin Exp Pharmacol Physiol. 1997;24:487-491 (Pubitemid 27273824)
11. Niwa Y, Nagata N, Oka M, et al. Production of nitric oxide from endothelial cells by 31-amino-acid-length endothelin-1, a novel vasoconstrictive product by human chymase. Life Sci. 2000;67:1103-1109 (Pubitemid 30485814)
12. Tawa M, Fukumoto T, Yamashita N, et al. Postconditioning improves postischemic cardiac dysfunction independently of norepinephrine overflow after reperfusion in rat hearts: comparison with preconditioning. J Cardiovasc Pharmacol. 2010;55:6-13
13. Imamura M, Lander HM, Levi R. Activation of histamine H3 receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia: comparison with adenosine A1-receptors and a2- adrenoceptors. Circ Res. 1996;78:475-481
14. McMurdo L, Thiemermann C, Vane JR. The endothelin ETB receptor agonist, IRL 1620, causes vasodilatation and inhibits ex vivo platelet aggregation in the anaesthetised rabbit. Eur J Pharmacol. 1994;259: 51-55
15. Mohan P, Brutsaert DL, Sys SU. Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovasc Res. 1995;29:637-640
16. Gourine AV, Gonon AT, Pernow J. Involvement of nitric oxide in cardioprotective effect of endothelin receptor antagonist during ischemia/ reperfusion. Am J Physiol Heart Circ Physiol. 2001;280:H1105-H1112
17. Liu S, Premont RT, Kontos CD, et al. Endothelin-1 activates endothelial cell nitric oxide synthase (eNOS) via heterotrimeric G-protein beta gamma subunit signaling to protein kinase B/Akt. J Biol Chem. 2003;278: 49929-49935 (Pubitemid 37548828)
18. Nakano D, Pollock JS, Pollock DM. Renal medullary ETB receptors produce diuresis and natriuresis via NOS1. Am J Physiol Renal Physiol. 2008;294:F1205-F1211
19. Tambascia RC, Fonseca PM, Corat PD, et al. Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats. Hypertension. 2001;37:1423-1428 (Pubitemid 34225386)
20. Hori S, Komatsu Y, Shigemoto R, et al. Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology. 1992; 130:1885-1895
21. Wendel M, Kummer W, Knels L, et al. Muscular ETB receptors develop postnatally and are differentially distributed in specific segments of the rat vasculature. J Histochem Cytochem. 2005;53:187-196 (Pubitemid 40194462)